Image Analysis as a Tool for Prognostic and Predictive Biomarkers in Breast Cancer – How Reliable Is It?

| June 15, 2010

Definiens Digital Pathology Webinar Series:

Image Analysis as a Tool for Prognostic and Predictive Biomarkers in Breast Cancer – How Reliable Is It?

June 30th, 11am EDT (4pm GMT)

Register: https://www2.gotomeeting.com/register/434138978

In this talk, Dr. Marilyn Bui and Mark Lloyd of the Moffitt Cancer Center will discuss their assessment of Definiens Tissue Studio for analysis of prognostic and predictive biomarkers in breast cancer.

The agenda for the webinar will be:

● Current standards in IHC and pathology
● Advantages of automated image analysis
● How Definiens Tissue Studio is used for digital pathology image analysis
● Case study comparing Definiens Tissue Studio analysis results with “gold standard” immunohistochemistry Her2 and ER best practices.
● Results

Speakers:

Dr. Marilyn Bui – Scientific Director, Analytic Microscopy Core, Moffitt Cancer Center, Tampa, Florida

Mark Lloyd – Staff Scientist, Analytic Microscopy Core, Moffitt Cancer Center, Tampa, Florida


Category: Digital Pathology News, Pathology News

Comments are closed.